Projects per year
Abstract
Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the effects of immune checkpoint inhibitors compared to chemotherapy as first- and second-line treatment of advanced or metastatic urothelial carcinoma.
| Original language | English (US) |
|---|---|
| Article number | CD013774 |
| Journal | Cochrane Database of Systematic Reviews |
| Volume | 2020 |
| Issue number | 11 |
| DOIs | |
| State | Published - 2020 |
Bibliographical note
Funding Information:We thank?the Cochrane Urology Editorial Group, the Methodological?Group and the Cancer Network for their support of this review. We thank G?nter Niegisch, Gunhild von Amsberg, Georgios?Gakis and Andrea Kokorovic?for reviewing the protocol.
Publisher Copyright:
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Copyright:
Copyright 2021 Elsevier B.V., All rights reserved.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Immunotherapy for advanced or metastatic urothelial carcinoma'. Together they form a unique fingerprint.Projects
- 1 Active
-
Systematic Review and Evidence Synthesis Service
Kocher, M. M. (Leader), Riegelman, A. L. (Leader) & Theis-Mahon, N. (Leader)
1/1/18 → …
Project: Other project
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS